Dr. Scott Trieber

Dr. Treiber is a CRO industry veteran with 28 years of clinical development experience. Most recently, Dr. Treiber was Chief Operating Officer at Elligo Health Research. Before that, he was Executive Vice President, Biopharmaceutical Development and GM at Chiltern. Dr. Treiber began his career as a Clinical Research Assistant at a large CRO. Since that time, 23 of his 28 years in the industry have been at CROs. He has also worked at Hospira and Elligo Health Research gaining valuable pharma and site network experience, respectively.

 

Dr. Treiber has expertise in clinical operations, clinical development, medical affairs, data management/statistics, pharmacovigilance/safety and quality. He has broad therapeutic expertise in neuroscience, oncology, hematology, pain, cardiovascular, gastroenterology, respiratory and women’s health.

 

Scott has a BA in biology from the University of Iowa, a PhD in neuroscience from the University of California Santa Cruz and an MBA from New York Institute of Technology.